Finding 1072793 (2023-001)

Significant Deficiency
Requirement
C
Questioned Costs
-
Year
2023
Accepted
2024-09-10

AI Summary

  • Core Issue: Lack of supervisory review for billing invoices, with two out of three invoices submitted by one person.
  • Impacted Requirement: Controls over the preparation and submission of monthly billing invoices are not being followed.
  • Recommended Follow-Up: Implement a process for documented review and approval of invoices by a different manager before submission.

Finding Text

Finding # 2023-001 Type: Significant deficiency Assistance Listing Number: 93.323 Epidemiology and Laboratory Capacity for Infectious Diseases Requirement: There should be controls over the preparation and submission of monthly billing invoices Condition/Context: Two out of three billing invoices tested were prepared by submitted by the same individual without supervisory review and approval before submission. Cause: The Organization was short staffed in the Finance Department during this time. Effect: Billing invoices may be inaccurate Questioned Costs: None. Recommendation: We recommend documented review and approval of billing invoices before submission by a member of management different from the preparer.

Categories

Significant Deficiency

Other Findings in this Audit

  • 496351 2023-001
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $371,185
93.959 Block Grants for Prevention and Treatment of Substance Abuse $345,713
93.391 Activities to Support State, Tribal, Local and Territorial (stlt) Health Department Response to Public Health Or Healthcare Crises $121,875